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Macrophages are intimately involved in the pathophysiology of
endometriosis, a chronic inflammatory disorder characterized by
the growth of endometrial-like tissue (lesions) outside the uterus.
By combining genetic and pharmacological monocyte and macro-
phage depletion strategies we determined the ontogeny and func-
tion of macrophages in a mouse model of induced endometriosis.
We demonstrate that lesion-resident macrophages are derived from
eutopic endometrial tissue, infiltrating large peritoneal macrophages
(LpM) and monocytes. Furthermore, we found endometriosis to trig-
ger continuous recruitment of monocytes and expansion of CCR2+
LpM. Depletion of eutopic endometrial macrophages results in
smaller endometriosis lesions, whereas constitutive inhibition
of monocyte recruitment significantly reduces peritoneal macro-
phage populations and increases the number of lesions. Reprog-
ramming the ontogeny of peritoneal macrophages such that
embryo-derived LpM are replaced by monocyte-derived LpM de-
creases the number of lesions that develop. We propose a putative
model whereby endometrial macrophages are “proendometriosis”
while newly recruited monocyte-derived macrophages, possibly in
LpM form, are “antiendometriosis.” These observations highlight
the importance of monocyte-derived macrophages in limiting
disease progression.
lesion | phenotype | ontogeny
Macrophages are exceptionally diverse cells present in alltissues of the body that perform functions vital for immunity,
development, tissue homeostasis, and repair following injury. They
modify their role depending on signals received from their local
microenvironment and accordingly exhibit high degrees of tran-
scriptional and phenotypic heterogeneity and tissue-specific function
(1, 2). Macrophages differ in their ontogeny. While early studies
suggested macrophages were continually replaced by circulating
blood monocytes, more recent lineage-tracing experiments dem-
onstrated that most tissue-resident macrophages (exceptions
include gut, dermis, and heart) are derived from embryonic
precursors that seed tissues prior to birth and are maintained by
self-renewal or longevity (3–5). Tissue-resident and monocyte-
derived macrophages play distinct roles both in health and dis-
ease (6). Usually, tissue-resident macrophages play tissue-specific
homeostatic roles as well as core functions such as clearance of
dying cells. On the other hand, monocyte-derived macrophages
that are recruited to tissues during inflammation secrete proin-
flammatory cytokines, help clear infection, and regulate the im-
mune response (6). Thus, in pathological situations, macrophages
are a heterogenous population. For example, during acute liver
injury hepatic resident macrophages (Kupffer cells) become acti-
vated and recruit monocytes that initially promote liver injury but
then subsequently differentiate into inflammatory macrophages
and help resolve injury and drive regeneration (7). In pancreatic
cancer, both tissue-resident and monocyte-derived macrophages
populate the tumor and increase in density as the cancer pro-
gresses. The two populations are transcriptionally diverse and
depletion studies revealed that only tissue-resident macrophages
are responsible for driving tumor progression (8). These findings
also highlight that under disease-modified conditions tissue-resident
macrophages can become adapted such that they promote disease.
Conversely, in other cancers (e.g., breast), monocytes are recruited
to the tumor and differentiate into tumor-associated macrophages
that drive disease (1).
The peritoneal cavity hosts two main macrophage populations:
a predominant population expressing high levels of epidermal
growth factor-like module-containing mucin-like hormone receptor-
like 1 (EMR1/F4/80) and low levels of major histocompatibility
class II (MHCII) known as large peritoneal macrophages (LpM),
and a less abundant population that are F4/80lo, MHCIIhi [small
peritoneal macrophages (SpM) (9)]. LpM are considered to be
tissue-resident macrophages and are largely embryonically derived;
however, it is now understood that they are gradually replaced by
monocytes over time in a sexually dimorphic manner that occurs
more quickly in males (10, 11). The transcription factor GATA6 is
highly expressed by all LpM in response to retinoic acid and drives a
significant proportion of the tissue-specific transcriptional signature
of these cells (12). The SpM population is a more heterogeneous
Significance
Endometriosis is a chronic, incurable inflammatory disorder
impacting 190 million women worldwide. Immune cells called
macrophages are implicated in promoting endometriosis. Macro-
phages have different origins and their origin can dictate function.
In this study we demonstrate that endometriotic lesion-resident
macrophages are derived from the uterine lining (endometrium),
the abdominal (peritoneal) cavity, and recruited bone-marrow pre-
cursors (monocytes). Endometriosis triggers continuous recruitment
of monocytes that differentiate into macrophages that differ from
those usually present within the peritoneal cavity. By depleting
different populations, we demonstrate that endometrial macro-
phages are “proendometriosis” while monocyte-derived peritoneal
macrophages are “antiendometriosis” acting to protect the cavity
from lesion establishment. In the future, immune-based therapies
may allow targeting of prodisease macrophages and/or harnessing
of antiendometriosis macrophages in endometriosis.
Author contributions: S.J.J. and E.G. designed research; C.H., K.P., P.D., and M.R. per-
formed research; M.M., D.S., and J.W.P. contributed new reagents/analytic tools; C.H.,
K.P., P.D., M.R., and E.G. analyzed data; and C.H., S.J.J., A.W.H., and E.G. wrote the paper.
The authors declare no competing interest.
This article is a PNAS Direct Submission. C.B.C. is a guest editor invited by the
Editorial Board.
This open access article is distributed under Creative Commons Attribution License 4.0
(CC BY).
1To whom correspondence may be addressed. Email: erin.greaves@warwick.ac.uk.
This article contains supporting information online at https://www.pnas.org/lookup/suppl/
doi:10.1073/pnas.2013776118/-/DCSupplemental.
Published February 3, 2021.










































population comprising monocyte-derived macrophages and den-
dritic cells that are continually replenished from the blood (10, 13).
Inflammatory challenge in the peritoneal cavity can result in re-
cruitment of large numbers of inflammatory macrophages that are
transcriptionally distinct from SpM (14), and a loss in LpM (the
so-called macrophage disappearance reaction), which results from
formation of cell aggregates (15) or cell death (16). An exception
to this is helminth infections which are characterized by expansion
of LpM in response to local Th2 cytokine production (14, 17–20).
Endometriosis is a chronic inflammatory condition where tissue
similar to the endometrium grows ectopically, usually in the
peritoneal cavity as “lesions” (21). The condition impacts an
estimated 190 million women worldwide and is associated with
debilitating pelvic pain and infertility (22). Currently, thera-
peutic options are very limited, with the gold-standard treat-
ments being surgical removal of lesions or suppression of
ovarian hormones. Surgery is associated with high recurrence
rates and ovarian suppression is contraceptive and often has
unwanted side effects. A high abundance of macrophages is
reported both in the peritoneal cavity and in lesions of women
with endometriosis (23). It is clear that macrophages are in-
trinsically linked with the pathophysiology of endometriosis,
where they enhance establishment, proliferation, and vascu-
larisation of lesions (24, 25). They are also critical in promoting
innervation of lesions and concomitant sensitization of nerve
fibers, thus contributing to pain in the condition (26, 27).
Fig. 1. Lesion-resident macrophages have different origins. Donor endometrial tissue from MacGreen mice was injected into the peritoneal cavity of wild-
type recipient mice to assess incorporation of endometrial macrophages into lesions. Lesions were collected at 2 wk after tissue injection in each of the
separate studies presented in this figure. (A) Expression of GFP by lesion-resident macrophages recovered from MacGreen (donor) to wild-type (recipient)
endometrial transfers (n = 6). (B) Quantification of donor endometrial-derived (GFP+) macrophages vs. recipient-derived (GFP−) macrophages. Dual immu-
nodetection for identification of LpM in lesions. (C) Dual immunodetection for F4/80 (red) and GATA6 (green; n = 7 mice [10 lesions]). Thick arrows indicate
dual-positive cells and thin arrows indicate GATA6− macrophages. (D) Quantification of F4/80+, dual-positive and GATA6+ cells in lesions. Fewer than 1% of
cells were dual-positive for F4/80 and GATA6. Adoptive transfers of MacGreen peritoneal macrophages into wild-type mice with GFP immunodetection to
assess incorporation of LpM and SpM into lesions. (E and F) Immunofluorescence for GFP on lesions collected following adoptive transfer of approximately
1 × 106 LpM (E) or SpM (F) isolated from MacGreen mice. Curved dotted line indicates the boundary between peritoneal and lesion tissue. In E, i and ii show
magnified images; in F, i shows a negative control. (G) Quantification of GFP+ LpM and SpM in lesions. Dual immunodetection for Ly6C+ monocytes in lesions.
(H) Dual immunodetection for F4/80 (red) and Ly6C (green) performed on mouse lesions. Data are presented as mean with 95% confidence intervals. Sta-
tistical significance was determined using a Student’s t test. ***P < 0.001.
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Evidence from a syngeneic mouse model of induced endome-
triosis indicates that donor endometrial macrophages as well as
host-derived macrophages can be identified in endometriosis
lesions (28). However, the exact origins of the host-derived
macrophages and specific functions of the different pop-
ulations remain to be determined.
Since macrophages play such a key role in many aspects of the
pathophysiology of endometriosis they represent an attractive
therapeutic target. However, the development of a viable immune-
therapy targeting “disease-promoting” macrophages or enhancing
the function of “protective” macrophages requires a comprehen-
sive understanding of the origin and function of lesion-resident
and associated peritoneal macrophages. In this study we have
characterized the origin of endometriosis lesion-resident macro-
phages and examined the dynamics of peritoneal cavity macrophage
populations. Finally, we have used a combination of transgenic and
pharmacological approaches to selectively deplete different pop-
ulations of macrophages to assess their impact on development of
endometriosis lesions.
Results
Endometriosis Lesion-Resident Macrophages Have Multiple Origins.
We induced endometriosis in wild-type C57BL/6 mice by injecting
“menses-like” endometrium fromMacGreen donor mice (Csf1r-eGFP;
macrophages are green fluorescent protein–positive [GFP+])
(29) into the peritoneal cavity as previously described (28). In
MacGreen mice all monocytes and macrophages in the shed
menses-like endometrium are GFP+ (30). Two weeks following
tissue injection, endometriosis lesions were collected, digested,
and analyzed by flow cytometry. GFP+ macrophages could be
detected among cluster of differentiation (CD)45+, lineage− (CD3,
CD19, CD335, sialic acid-binding immunoglobulin-type lectin F
[SIGLEC-F]), Lymphocyte antigen 6 complex, locus G6D (Ly6G)−,
integrin alpha M (CD11b)+ lesion cells (Fig. 1A). These data
indicate that macrophages derived from the donor endometrium
reside within lesions and verifies our previous findings using
immunodetection (28). Endometrial-derived macrophages (GFP+)
represented 16.0% (SD ± 8.6) of lesion-resident macrophages,
while the remaining 84.0% (GFP−; SD ± 8.4) were host-derived
infiltrating populations (Fig. 1B). Next, we sought to determine
the origin of the host-derived infiltrating cells. We investigated
infiltration of LpM into endometriosis lesions using dual immu-
nodetection for F4/80 (red) and the transcription factor GATA
binding protein 6 (GATA6; LpM marker, green; Fig. 1C).
Quantification of dual-positive cells revealed that less than 1.0%
of lesion-resident cells were derived from LpM (Fig. 1D). To
verify these findings, we performed adoptive transfer of GFP+
LpM isolated by fluorescent activated cell sorting (FACS) from
MacGreen mice (LpM and SpM were determined based on expres-
sion of F4/80 and MHCII, discussed below). GFP+ macrophages
Fig. 2. Monocyte recruitment and replenishment of peritoneal macrophage pools in mice with induced endometriosis. (A) LpM (F4/80hi, MHCIIlo) and SpM
(F4/80lo, MHCIIhi) populations in the peritoneal fluid of mice. (B) Quantification of LpM and SpM of sham (n = 6 to 8 at each time point) and endometriosis
mice at 1 (n = 6), 2 (n = 8), and 3 wk (n = 16) after endometrial tissue injection compared to naïve mice (n = 12). (C) Flow plot indicating gating of monocytes
(F4/80lo, Ly6Chi) in peritoneal lavage fluid. (D) Quantification of monocyte numbers of sham and endometriosis mice at 1, 2, and 3 wk after tissue injection. (E)
Flow plot demonstrating expression of Ccr2 on F4/80hi macrophages in peritoneal lavage fluid from sham vs. endometriosis mice (2 wk after tissue injection).
(F) Quantification of CCR2+, F4/80hi cells from endometriosis mice (n = 5) compared to sham (n = 4) and naïve (n = 4) mice. Data are presented as mean ± SEM.
Statistics were determined using a one-way ANOVA and a Tukey post hoc test. *P < 0.05, **P < 0.01.
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could be easily detected in lesions (Fig. 1E), suggesting that LpM
infiltrate endometriosis lesions and lose expression of GATA6,
consistent with a change in phenotype within the lesion micro-
environment. Conversely, very few GFP+ macrophages were de-
tected in lesions following adoptive transfer of SpM isolated
from MacGreen mice, suggesting that significant trafficking of
peritoneal macrophages to lesions was restricted to the LpM
population (Fig. 1F). Interestingly, GFP+ SpM were instead ob-
served located to the peritoneum adjacent to lesions. Quantifica-
tion of GFP immunofluorescence revealed that a mean of 27.4%
of cells in lesions were derived from LpM and a mean of 3.6%
were derived from SpM (Fig. 1G). To assess infiltration of mono-
cytes into lesions we used dual immunodetection for F4/80 (red)
and Lymphocyte antigen 6 complex, locus C (Ly6C; green). We
identified Ly6C-positive lesion-resident monocytes and a pop-
ulation of dual-positive cells (yellow) were also detected, indicating
that monocytes infiltrated lesions and differentiated in situ into
macrophages (Fig. 1H).
Continuous Recruitment and Contribution of Monocytes to Peritoneal
Macrophage Populations in Mice with Induced Endometriosis. Next,
we investigated macrophage populations present in the perito-
neal cavity of mice with induced endometriosis. From CD45+,
Ly6G−, lineage− cells, LpM and SpM were determined based on
expression of F4/80 and MHCII (Fig. 2A). At 1 wk after tissue
injection, LpM (F4/80hi, MHCIIlo) numbers were significantly
higher in sham mice (ovariectomized and treated with estradiol
valerate and subject to intraperitoneal [i.p.] injection of phosphate-
buffered saline instead of endometrial tissue) compared to naïve
mice (mean ± SEM = 48,399 ± 7,361 cells per microliter in sham
and 18,969 ± 5,989 cells per microliter in naïve; Fig. 2B; P < 0.01).
At 3 wk, LpM numbers in sham animals had decreased compared
to 1 wk (P < 0.05). In contrast, no significant differences were found
in the LpM population in mice with endometriosis compared to
naïve and sham animals or within the endometriosis group at dif-
ferent time points. However, a trend can be observed indicating a
moderate decrease in LpM numbers at 1 wk after tissue injection in
endometriosis mice compared to sham. This suggests that, com-
pared to sham controls, there may be some loss of LpM following
transfer of endometrial tissue, and this could be attributed to LpM
trafficking into lesions or possible clotting of LpM as seen in peri-
tonitis models (31). By 3 wk the trend toward decreased LpM in
endometriosis mice compared to sham is no longer evident and is
consistent with our previous reports demonstrating an increase in
LpM at 3 wk in mice with endometriosis (26). SpM (F4/80lo,
MHCIIhi) numbers were consistent between all groups of animals
and time points. Ovariectomy alone can have striking impacts on
macrophage pools present in the peritoneal cavity and leads to
increased macrophage replenishment (11). We repeated our re-
sults using intact recipient mice and confirmed that in this mini-
mally invasive model there was no distinct shift in the ratio of SpM
to LpM, suggesting that transfer of endometrial tissue does not
disrupt the normal balance of peritoneal macrophages (SI Ap-
pendix, Fig. S1A). Monocytes in the peritoneal cavity were iden-
tified by expression of Ly6C (detection of classical monocytes;
Fig. 2C) and numbers were significantly increased in mice with
induced endometriosis at 1 wk after tissue injection compared to
naïve mice (Fig. 2D; P < 0.01). Monocyte numbers remained el-
evated between weeks 1 and 3 in mice with induced endometriosis,
suggesting continuing recruitment to the peritoneal cavity as a
consequence of the presence of endometriotic lesions. To begin to
investigate the fate of monocytes recruited to the peritoneal cavity
of mice with induced endometriosis, we evaluated expression of
C-C chemokine receptor type 2 (CCR2; mediates monocyte che-
motaxis/recruitment of monocytes) by F4/80hi (LpM) macro-
phages in the peritoneal cavity using flow cytometry. Significantly
elevated numbers of F4/80+, CCR2+ macrophages were recor-
ded in mice with induced endometriosis (Fig. 2 E and F),
suggesting that increased numbers of monocyte-derived LpM are
evident in mice with endometriosis. In steady-state conditions,
long-lived embryo-derived peritoneal macrophages express T cell
immunoglobulin and mucin domain containing 4 (TIM4), while
recently monocyte-derived LpM do not (10); thus, to further
validate our hypothesis we ascertained TIM4 expression in F4/80hi
LpM in intact mice. We found a significant reduction in TIM4hi
LpM at weeks 2 and 3 compared to week 1 (SI Appendix, Fig. S1B;
P < 0.05) and a concomitant increase in TIM4lo LpM at weeks 2
(P < 0.05) and 3 (P < 0.01) compared to week 1 (SI Appendix, Fig.
S1B). This finding is consistent with heightened monocyte input
into the LpM pool in endometriosis. We also observed a signifi-
cant reduction in the proportion of F4/80lo, MHCII− cells within
the CD11b+ peritoneal population between week 1 and week 3
after endometrial tissue injection (SI Appendix, Fig.S1 C and D).
Only a minor proportion of these cells express Ly6C (less than 2%
of CD11b cells), indicating that this population may be a transitory
state between monocyte and LpM.
Endometrial Macrophage Depletion Leads to Reduced Endometriotic
Lesion Size. To dissect the role of macrophages with different
ontogenies in endometriosis we used a number of depletion
strategies. To deplete endometrial macrophages, doxycycline was
administered to iCsf1r-KO donor mice from days 15 to 19 after
ovariectomy (Fig. 3A), such that we could achieve macrophage
depletion by inducibly ablating expression of Csf1r (32). Pre-
transfer analysis revealed that the endometrium was significantly
depleted of F4/80hi macrophages (Fig. 3B; P < 0.05). Following
transfer of macrophage-depleted donor endometrial tissue to
wild-type recipients, there was no difference in the number of
lesions recovered after 2 wk (Fig. 3C); however, the lesions re-
covered were significantly smaller than those from mice receiving
wild-type endometrium (Fig. 3D; P < 0.05). These data suggest
that macrophages within endometrial tissue promote the growth
of endometriosis lesions but do not significantly impact the at-
tachment of endometrial tissue to the peritoneal lining.
“Monocytopenic” Mice with Induced Endometriosis Had an Increased
Number of Lesions. Previous studies have inferred a role for re-
cipient peritoneal macrophages in lesion development since
continual i.p. delivery of clodronate liposomes or anti-F4/80
antibody throughout the growth phase resulted in smaller lesions
(24). Further, i.p. transfer of bone marrow (BM)-derived mac-
rophages could enhance or inhibit growth dependent on polari-
zation of macrophages in vitro prior to transfer (24). However, in
addition to embryo-derived resident peritoneal macrophages, it
is possible these methods also deplete endometrial macrophages
(in transferred endometrial tissue) and recruited monocyte-
derived cells. Notably, these studies showed that liposome-
mediated depletion of embryonic resident peritoneal macro-
phages prior to endometrial transplantation did not significantly
affect lesion development (24), suggesting the role of embryonic
LpM is, at best, redundant. Hence, we next aimed to prevent
recruitment of host monocytes to the peritoneal cavity and le-
sions using Ccr2 null monocytopenic recipient mice. LpM, SpM,
and monocytes were all significantly reduced in the peritoneal
lavage fluid of Ccr2−/− mice with induced endometriosis com-
pared to wild-type mice with endometriosis (a reduction of
56.4%, 70.5%, and 69.0% in mean values respectively; Fig. 4 A–
E and SI Appendix, Fig. S2 A–C). This supports the concept that
in our mouse model of endometriosis monocytes are continu-
ally recruited and contribute to the LpM and SpM pools. Fur-
thermore, while lesion size was not different between the two
groups (Fig. 4G), Ccr2−/− mice had significantly more lesions
(P < 0.01) compared to wild-type mice (Fig. 4F). This indicates that
monocytes or monocyte-derived macrophages normally protect
against establishment of lesions. To validate these findings,
we repeated the experiment in Chemokine (C-C motif) ligand 2
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null (Ccl2−/−) mice. In Ccl2−/− mice with endometriosis, LpM
and SpM were significantly depleted compared to wild-type mice
with endometriosis (a reduction of 37.9% and 69.8% in mean
values respectively; Fig. 5 A–C; P < 0.05 and SI Appendix, Fig.
S2 D–F). We observed a concomitant increase in the number of
lesions recovered from Ccl2−/− mice (Fig. 5E; P < 0.05). Strik-
ingly, Ccr2−/−and Ccl2−/− mice with induced endometriosis were
still able to recruit Ly6C+ monocytes from the BM to the
peritoneal cavity despite monocytes being absent in the perito-
neal lavage of naïve and sham monocytopenic mice (SI Appendix,
Fig. S3). Moreover, in lesions recovered from Ccr2−/− and
Ccl2−/− mice we could still detect monocytes using immunode-
tection (Figs. 4 H and I and 5 G and H), indicating that there is
redundancy in the CCL2–CCR2 axis in the presence of endo-
metriosis lesions and suggesting that monocytes may also be
recruited via another mechanism.
Transient Depletion of Monocytes Did Not Impact Establishment of
Endometriotic Lesions. Next, we sought to transiently deplete
monocytes to ascertain the role of undifferentiated monocytes in
lesion development while leaving the peritoneal macrophage
populations relatively unaltered. We depleted monocytes using a
function-blocking CCR2 monoclonal antibody (MC21) injected
into the peritoneal cavity of mice with induced endometriosis.
Mice were injected with MC21 6 h prior to transfer of endo-
metrial tissue and every following day for 4 d (Fig. 6A). Com-
pared to a control immunoglobulin G (IgG) antibody (MC67),
MC21 triggered an expansion of LpM (Fig. 6C; P < 0.05), did not
modify SpM (Fig. 6D), and significantly reduced the number of
monocytes in the peritoneal cavity (Fig. 6 B and E; P < 0.05). In
mice with induced endometriosis treated with MC21 there was
no difference in lesion number or size compared to mice treated
with control MC67 (Fig. 6 F and G). These results rule out the
possible contribution of recently recruited monocytes to the
“antiendometriosis” function of monocyte-derived cells observed
in Figs. 4 and 5.
Reprogramming the Ontogeny of Macrophages in the Peritoneal
Cavity of Mice with Induced Endometriosis Leads to Reduced Lesion
Size. Next, we aimed to confirm the protective role of monocyte-
derived LpM against establishment of lesions by reprogramming
the ontogeny of macrophages in the peritoneal cavity. Seven days
following ovariectomy we depleted peritoneal macrophages using
liposomal clodronate and allowed 19 d (33) for replenishment of
the niche from monocytes prior to injection of donor endometrial
tissue (Fig. 7A). Compared to control mice with induced endo-
metriosis, those with reprogrammed cavities exhibited elevated
LpM and SpM (Fig. 7 C and D; P < 0.05 and P < 0.001 respec-
tively). Moreover, endometriosis mice with reprogrammed cavities
were significantly depleted of TIM4hi LpM (a reduction of 82.7%
in mean values compared to control mice with endometriosis;
Fig. 7E; P < 0.01) consistent with replacement of embryo-derived
LpM with monocyte-derived LpM (10, 33). In mice with reprog-
rammed cavities, the number of lesions that developed was
significantly reduced, with five mice developing no lesions at all
(P < 0.05; Fig. 7F). There was no difference in lesion area in
mice with reprogrammed cavities compared to control mice
(Fig. 7G). Collectively, these data strongly support the concept
that monocyte-derived LpM act to protect the peritoneal cavity
when challenged with ectopic endometrial tissue.
Discussion
The pathophysiology of endometriosis remains enigmatic (21).
Although immune cell dysfunction is intrinsically linked with the
disorder, our understanding of macrophage origins and respec-
tive function remains limited compared with other diseases, such
as cancer (34). As the ontogeny of macrophages in diseased
tissue is a key determinant of how they respond and contribute to
pathogenesis, it is necessary to understand how macrophages
derived from different sources impact lesion development. In the
current study we have determined, in a mouse model of induced
endometriosis, that lesion-resident macrophages are derived
from the eutopic endometrium, infiltrating LpM and monocytes.
We have demonstrated that endometriosis triggers continuous
Fig. 3. Endometrial macrophage depletion impacts lesion size. (A) Schematic demonstrating timing of doxycycline administration to iCsf1r-KO donor mice.
Donor endometrium was generated in iCsf1r-KO mice, with doxycycline administered to donor mice from days 15 to 19 to deplete endometrial macrophages
prior to recovery of endometrium and i.p. transfer to wild-type recipients. Lesions were recovered 2 wk after tissue injection. (B) Quantification of F4/80hi,
Ly6Clo macrophages and Ly6Chi, F4/80lo monocytes in donor endometrium from wild-type and iCsf1r-KO mice. (C) Number of lesions recovered from wild-type
recipient mice receiving either wild-type (n = 10) or iCsf1r-KO endometrium (n = 9) (from two independent experiments). (D) Area of lesions recovered from
mice receiving either wild-type or iCsf1r-KO endometrium. Data are presented as mean ± SEM or 95% confidence intervals (C). Statistical significance was
determined using a Student’s t test. *P < 0.05.
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recruitment of monocytes to the peritoneal cavity and heightened
monocyte input into the LpM pool. We show that endometrial
macrophages promote the growth but not the establishment of
endometriotic lesions, whereas monocyte-derived LpMs play a
protective role against lesion development.
The contribution of embryonic-derived and monocyte-derived
macrophages to the “tissue-resident” population is different in
each tissue (3–5). We previously demonstrated that macrophages
present in the endometrium can be detected in lesions recovered
from our model of induced endometriosis (28). However, little is
known regarding the ontogeny of macrophages in the endome-
trium. In a mouse model of menstruation, utilizing MacGreen
(Csf1r-EGFP) mice, Cousins et al. (30) demonstrated that three
populations could be distinguished in the endometrium using
dual staining for F4/80 and GFP: 1) a population of GFP+, F4/
80− cells likely to be infiltrating monocytes, 2) a population of
GFP+, F4/80+ cells suggestive of monocyte-derived macro-
phages, and 3) a population of putative (but not confirmed with
lineage tracing) “tissue-resident” macrophages that are GFP−,
F4/80+. The cells were localized to areas of breakdown, repair,
and remodeling, respectively. The “menses-like” endometrium
that we recover from donor mice for transfer into recipient mice
is collected at the initiation of the “breakdown” phase and is
most likely to consist of monocytes and monocyte-derived mac-
rophages. Moreover, the tissue collected is the “decidual” mass
only and does not include the compartment of the uterus where
putative “tissue-resident” macrophages are located. Using an
inducible Csf1r knockout to generate donor endometrium we
achieved depletion of macrophages (F4/80hi, Ly6Clo) and limited
the number of monocytes (F4/80lo, Ly6Chi) in the tissue trans-
ferred to recipient mice. We did not observe any difference in
the number of lesions formed between recipient mice that re-
ceived wild-type or macrophage-depleted endometrium; how-
ever, we did find that the lesions recovered were significantly
smaller in mice receiving macrophage-depleted endometrium,
indicating that endometrial macrophages play a critical role in
Fig. 4. ”Monocytopenic” mice with induced endometriosis establish more lesions. (A) Schematic demonstrating experimental design. Wild-type donor
endometrium was generated as previously shown (Fig. 3A) and injected i.p. into ovariectomized Ccr2−/− recipients. Wild-type recipients were also used as
controls. Lesions were recovered 2 wk after tissue injection. (B) Flow plot indicating gating and number of LpM (F4/80hi) and SpM (MHCIIhi) in peritoneal
lavage fluid recovered from wild-type (n = 7) and Ccr2−/− mice (n = 8) with induced endometriosis. (C–E) Quantification of (C) LpM, (D) SpM, and (E)
monocytes (Ly6Chi) in peritoneal lavage fluid. (F) Number of lesions recovered from wild-type (n = 11) and Ccr2−/− (n = 13) mice with induced endometriosis
(from three independent experiments). (G) Size of lesions recovered from wild-type and Ccr2−/− mice with induced endometriosis. (H) Dual immunodetection
for Ly6C (green) and F4/80 (red) on lesions recovered from wild-type and Ccr2−/− mice. (I) Quantification of monocytes (Ly6C+; yellow bars) and monocyte-
derived macrophages (Ly6C+, F4/80+; green bars) in lesions recovered from wild-type and Ccr2−/− mice. Data are presented as mean ± SEM or 95% confidence
intervals (F). Statistical significance was determined using a Student’s t test or Mann–Whitney U test. *P < 0.05, **P < 0.01, ***P < 0.001.
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growth of lesions. The breakdown phase of the (donor) endo-
metrium is analogous to the initial inflammatory phase of the
wound-healing process where proinflammatory macrophages
play a vital role prior in wound repair (35). If we consider
endometriotic lesions as chronic wounds that do not fully resolve
their inflammation, we may presume that the initial inflamma-
tory phase begins as the endometrium breaks down during
menstruation (or within the established lesion during cyclical
remodeling) and the repair of the translocated endometrium
occurs in the peritoneal cavity, resulting in the formation of le-
sions. The subsequent phase of the tissue repair process is the
proliferative phase: In mouse models of skin injury, macro-
phage depletion during this phase resulted in granulation tissue
that had very few blood vessels and proliferative cells and a
significant reduction in wound closure. This indicates that
macrophages support this phase by promoting endothelial cell
survival and vascularization, which facilitates proliferation (36).
We suggest that a similar process occurs in mice receiving en-
dometrium depleted of monocytes and macrophages and this
may explain reduced lesion size in recipient mice. Further, pre-
vious studies have demonstrated that macrophages do not reg-
ulate survival or proliferation of uterine epithelial, stromal, or
vascular endothelial cells during the estrus cycle or following
exogenous supplementation with estradiol and progesterone
(37). This evidence supports the concept that macrophages are
implicated in tissue repair after hormone withdrawal or injury
(e.g., following endometrial shedding and in endometriosis), as
opposed to having a trophic role under steady-state conditions.
The ontogeny of peritoneal macrophages is better charac-
terized. LpM are embryo-derived and long-lived and undergo
Fig. 5. More lesions are evident in Ccl2−/− mice. Wild-type donor endometrium was generated as previously shown (Fig. 3A) and injected i.p. into ovari-
ectomized Ccl2−/− recipients as in the previous figure. Wild-type recipients were also used as controls. Lesions were recovered 2 wk after tissue injection. (A)
LpM and SpM populations in peritoneal lavage fluid from wild-type and Ccl2−/− mice with induced endometriosis. (B–D) Quantification of (B) LpM, (C) SpM,
and (D) monocytes in peritoneal lavage fluid from wild-type (n = 5) and Ccl2−/− (n = 5) mice with induced endometriosis. (E) Number of lesions recovered
from wild-type and Ccl2−/− mice. (F) Size of lesions recovered from wild-type (n = 6) and Ccl2/- (n = 7) mice with induced endometriosis (from two
independent experiments). (G) Dual immunodetection for Ly6C (green) and F4/80 (red) on lesions recovered from wild-type and Ccl2−/− mice. (H) Quantifi-
cation of monocytes (Ly6C+) and monocyte-derived macrophages (Ly6C+, F4/80+) in lesions recovered from wild-type and Ccl2−/− mice. Data are presented as
mean ± SEM or 95% confidence intervals (E). Statistical significance was determined using a Student’s t test or Mann–Whitney U test. *P < 0.05.
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self-renewal; however, monocytes do continually enter the peri-
toneal cavity via CCR2, where they continually replenish the
SpM compartment and infrequently differentiate into LpM (10).
Such replenishment of LpM occurs in a sexually dimorphic
manner, occurring more quickly in male compared to female
mice who retain their embryo-derived LpM for much longer (10,
16), and it is likely that in adult female mice of the age used in
our studies (10 to 12 wk) only 10 to 30% of peritoneal LpM
would be derived from adult monocytes (11, 16). In this study we
used ovariectomy and estradiol supplementation of recipient
animals to allow optimal lesion development. Peritoneal surgery
increases the contribution of monocytes to the peritoneal LpM;
however, the embryonic component would still be expected to
comprise ∼50% of the population at the time of injection of
endometrial material. Although monocyte-derived LpM mostly
phenocopy embryo-derived LpM, transcriptomically they exhibit
some differences. For example, embryo-derived LpM express
Timd4, while in steady state many monocyte-derived LpM do
not, or take significant time to do so (10, 11). Notably, the
number of monocytes and CCR2+ LpM was significantly ele-
vated in the peritoneal cavity of mice with induced endometri-
osis, above levels seen in ovariectomized controls, suggesting
monocytes are continually recruited and contribute to LpM
pools during lesion development.
Consistent with a significant input of monocytes to LpM
in endometriosis, our most striking result was revealed by
constitutively limiting monocyte recruitment (using both Ccr2−/−
and Ccl2−/− mice) and subsequently reducing both LpM and
SpM replenishment, which resulted in mice with induced
endometriosis developing significantly more lesions. When left
unmanipulated, female Ccr2−/− mice and wild-type controls
normally exhibit equivalent numbers of LpM (10). Thus, we
suggest that monocyte-derived macrophages act to protect the
peritoneal cavity and can limit the establishment of lesions
(Fig. 8).
In monocytopenic mice with endometriosis, a reduction in
SpM and LpM as well as monocytes was observed. Mono-
cytopenic mice also exhibited significantly more lesions, indi-
cating that monocyte-derived cells are “antiendometriosis,”
although to which population of monocyte-derived cells this
function can be attributed remains uncertain. As transient
antibody-mediated depletion of monocytes during the estab-
lishment phase failed to increase the number of lesions but also
left SpM and LpM populations intact, it seems likely that either
SpM or LpM provide a dominant antiendometriosis effect.
We determined that a significant proportion of LpM (27.4%
of lesion resident cells were GFP+ following adoptive transfer of
LpM) but not SpM enter endometriosis lesions using adoptive
transfers; we suggest that these LpM change phenotype in le-
sions very rapidly because only a few lesion cells positive for both
F4/80 and GATA6 (<1%) were identified using dual staining,
whereas LpM in the cavity are almost entirely positive for
GATA6 (12). Aside from identifying peritoneal LpM as a source
of macrophages in endometriosis lesions, these findings are im-
portant because they show that LpM are able to reprogram and
survive in ectopic tissue, a topic of significant controversy in the
field of tissue-resident macrophage biology (38, 39). Indeed, our
results are consistent with the reversible expression of GATA6
Fig. 6. A function-blocking Ccr2 mAb reduces monocyte numbers without significant impact on lesion number. (A) Schematic showing the experimental
design; mice with induced endometriosis were treated with a control IgG (MC67; n = 9) or a function-blocking CCR2 mAb (MC21; n = 10, from two inde-
pendent experiments) 6 h prior to endometrial tissue injection and daily for an additional 4 d. Lesions were recovered 5 d after tissue injection. (B) Flow plot
demonstrating the numbers of Ly6Chi monocytes in mice with induced endometriosis treated with MC67 or MC21. (C–E) Quantification of (C) LpM, (D) SpM,
and (E) monocytes in the peritoneal lavage fluid of mice with induced endometriosis. (F) Number of lesions recovered from mice treated with MC67 or MC21.
(G) Size of lesions recovered from mice treated with MC67 or MC21. Data are presented as mean ± SEM or 95% confidence intervals (F). Statistical significance
was determined using a Student’s t test or a Mann–Whitney U test. *P < 0.05.
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by LpM in the absence of sustained retinoic acid receptor sig-
naling (12) and mirror recent findings that pericardial cavity
GATA6+ macrophages lose expression of GATA6 following
recruitment to areas of ischemic heart disease (40). In the same
manner, mature F4/80hi GATA6+ peritoneal LpM are reported
to traffic directly across the mesothelium into the liver following
sterile injury. Once in the liver, the macrophages undergo local
proliferation and up-regulation of markers of alternative acti-
vation, such as Arginase 1 (Arg1) and Retnla. In the absence of
peritoneal macrophages, healing was significantly delayed (41).
Our data suggest that in endometriosis LpM trafficking to lesions
may play a similar role, perceiving the ectopic tissue as a wound
and activating repair processes. Interestingly, GATA6-positive
macrophages that invade the epicardium from the pericardial space
following experimental myocardial infarction were antifibrotic,
despite a rapid loss of GATA6 expression (40). Fibrosis is a
consistent feature of endometriotic lesions (42). While eutopic
endometrium is able to undergo scar-free healing to restore full
tissue functionality, when the tissue is translocated to the perito-
neal environment fibrotic “repair” occurs to form lesions. The
mechanisms responsible for this are yet to be fully resolved but
prorepair macrophages have been implicated in the process (43).
Thus, it seems unlikely that LpM trafficking into lesions contribute
to fibrotic repair; however, the ontogeny of macrophages con-
tributing to fibrogenesis in endometriosis remains to be deter-
mined. Interestingly, our data suggest that SpM (which likely
include both classical dendritic cells [cDC]1 and cDC2, with the
flow cytometry gates used in our study) may have a neutral role in
the pathophysiology of endometriosis since they neither increased
in number nor appeared to significantly contribute to the lesion-
resident population. Moreover, in our final experiment we sought
to reprogram the peritoneal cavities of mice such that embryo-
derived LpM were replaced by monocyte-derived LpM. In endo-
metriosis mice with reprogrammed cavities significantly fewer le-
sions developed. Hence, we suggest it is the monocyte-derived
LpM that are protective against development of endometriosis.
One limitation of the current study is the interexperiment
variation in lesion number and size in wild-type mice. The mouse
model of induced endometriosis used in the study relies on
spontaneous attachment of the donor endometrial tissue to the
peritoneal lining of recipient mice. This avoids the additional
inflammation triggered by suturing (used in a number of other
models). We carefully control the amount of tissue used to in-
oculate recipient mice, and any donor mice that do not mount
the appropriate decidual response are excluded. One possible
cause that may impact the efficacy of endometrial tissue at-
tachment is a discrete difference in the immune status of batches
of mice. Future studies will determine ontogenetic and phenotypic
differences in peritoneal macrophages recovered from mice with
varying degrees of endometrial tissue attachment.
Our data indicate a key role for monocyte recruitment to the
peritoneal cavity and ectopic tissue in endometriosis. We readily
detected lesion-resident monocytes as well as cells that were double-
positive for both Ly6C and F4/80, but whether this indicates that
monocytes rapidly differentiate in lesions or that differentiated
monocyte-derived macrophages are recruited from the peritoneal
cavity remains unclear. We speculate that monocyte-derived cells
represent the largest lesion-resident population. However, we
Fig. 7. Reprogramming the ontogeny of peritoneal macrophages leads to establishment of fewer lesions. (A) Schematic showing the experimental design;
7 d after ovariectomy experimental mice were administered i.p. with liposomal clodronate to deplete all peritoneal macrophages (n = 10). Nineteen days
were allowed for replenishment of the niche prior to transfer of endometrial tissue on day 26. Lesions were recovered 5 d after tissue injection. Control mice
(n = 10) did not receive liposomal clodronate (single independent experiment). (B) Flow plot demonstrating the numbers of TIM4hi and TIM4lo LpM in control
mice with induced endometriosis or mice with reprogrammed cavities with induced endometriosis. (C–E) Quantification of (C) LpM, (D) SpM, and (E) TIM4hi
LpM in the peritoneal lavage fluid of mice with induced endometriosis. (F) Number of lesions recovered from control mice and those with reprogrammed
cavities. (G) Size of lesions recovered from control mice and those with reprogrammed cavities. Data are presented as mean ± SEM or 95% confidence in-
tervals (F). Statistical significance was determined using a Student’s t test or a Mann–Whitney U test. *P < 0.05, **P < 0.01, ***P < 0.001.
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cannot currently conclude whether these are monocyte-derived
LpM or monocytes recruited directly to the lesion. If the latter,
we do not know whether these come via the cavity or through the
newly formed vasculature associated with the lesion.
In a previous study, Bacci et al. (24) depleted peritoneal mac-
rophages using liposomal clodronate in a mouse model of endo-
metriosis. Depletion of peritoneal macrophages prior to transfer
of endometrial tissue had no significant impact on lesion estab-
lishment and growth, implying that embryonic-derived LpM are
redundant in lesion development. Continuous depletion during
establishment and growth resulted in significantly smaller lesions,
allowing the authors to conclude that the dominant role for
macrophages in endometriosis is to promote the development of
lesions. It may be presumed that this approach has the potential to
deplete all monocytes and macrophages, including those in the
transferred endometrial tissue. Thus, in light of our findings that
donor endometrial macrophages play a significant role in facili-
tating lesion growth we suggest the findings of Bacci et al. (24) are
a consequence of global macrophage depletion. In contrast, our
study used depletion strategies that target macrophages from
different origins. We demonstrate a protective role for monocyte-
derived macrophages (presumably in LpM form). Similarly, fur-
ther experiments by Bacci et al. demonstrated that i.p. transfer of
BM-derived macrophages could enhance or inhibit growth de-
pendent on polarization of macrophages in vitro prior to transfer
(24). Further studies will aim to elucidate the exact phenotype and
mechanism of monocyte-derived LpM in endometriosis.
Definition of the macrophage populations that reside in dis-
eased tissues is vital for understanding macrophage-driven pa-
thology, particularly for endometriosis where little is known about
the lesion macrophage niche. In the future it may be possible to
harness the protective properties of monocyte-derived macro-
phages as a potential therapy for women with endometriosis. We
propose a putative model that in endometriosis macrophages
derived from the endometrium exhibit “proendometriosis” func-
tions and facilitate growth of endometriotic lesions, whereas
monocyte-derived cells, possibly in the form of LpM from the
cavity, have an “antiendometriosis” role and are protective against
persistence of ectopic tissue and establishment of lesions.
Collectively, we have demonstrated multiple origins for endo-
metriotic lesion-resident macrophages, a key role for monocyte-
derived macrophages in protecting the peritoneal cavity when
challenged with ectopic endometrial tissue, and a pathological role
for endogenous endometrial macrophages. Our findings imply that
monocyte recruitment or monocyte-derived macrophages may be
defective in women with endometriosis, and this should be ex-
plored in more depth in women with the condition. Thus, we have
opened up avenues and possibilities for how macrophages can be
targeted or harnessed as a therapeutic option in the treatment of
endometriosis.
Materials and Methods
Animals and Reagents. Wild-type C57BL/6JOIaHsd female mice were pur-
chased from Harlan (Harlan Sprague Dawley Inc.) at 8 to 12 wk of age. All
transgenic lines used in this study were on the C57BL/6 background and
were bred and maintained at the University of Edinburgh or the University
of Warwick. All animal work was licensed and carried out in accordance with
the UK Home Office Animal Experimentation (Scientific Procedures) Act
1986 and the work licensed under PPL 70/8731 (E.G.). Mice had access to
food and water ad libitum and were kept at an ambient temperature and
humidity of 21 °C and 50%, respectively. Light was provided 12 h a day from
7 AM to 7 PM. Further details are available in SI Appendix, Materials and
Methods.
Mouse Model of Induced Endometriosis. Endometriosis was induced in mice
using a syngeneic model as previous described (28). The model aims to mirror
the process of “retrograde menstruation.” Further details are available in SI
Appendix, Materials and Methods.
Fig. 8. Monocyte-derived macrophages are guardians of the peritoneal cavity in mice with induced endometriosis. Created with https://biorender.com/.
Lesion-resident macrophages are a heterogenous population constituted by macrophages that have different origins; endometrial, peritoneal (LpM), and
recruited monocytes that differentiate into macrophages in lesions. Wild-type mice with induced endometriosis exhibit increased monocyte recruitment and
replenishment of LpM pools from monocytes. In mice where monocyte recruitment is constitutively limited (Ccr2−/− or Ccl2−/−), LpM and SpM pools are
significantly reduced, consistent with the majority of LpM in the peritoneal cavity being embryo-derived. In these (monocytopenic) mice, more lesions de-
velop. Mice with ontogenetically reprogrammed peritoneal cavities (embryo-derived LpM depleted using liposomal clodronate followed by a 19-d replen-
ishment window) develop significantly fewer lesions. Collectively, these data suggest that monocyte-derived LpM protect the peritoneal cavity when
challenged with ectopic endometrial tissue. We propose a putative model where endometrial macrophages promote lesion growth, while monocyte-derived
macrophages (possibly monocyte-derived LpM) protect the peritoneal cavity against establishment of lesions.
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Flow Cytometry. Endometrium or lesions were dissected, pooled from each
mouse, and placed in 2 mL of ice-cold DMEM. Tissues were cut into small
pieces using a scalpel and digested with 1 unit of Liberase DL, 1 unit of
Liberase TL, and 0.6 mg DNase enzymes. The tissue and enzymes were in-
cubated for 45 min at 37 °C, with vortexing every 5 min. Following digestion
samples were filtered through 100-μM filters. Red blood cells were lysed
from peritoneal lavages and cells derived from the endometrium or lesions,
and approximately 106 cells per sample were blocked with 0.025 mg anti-
CD16/32 (clone 93; BioLegend) and then stained with a panel of antibodies
shown in SI Appendix, Table S1. Brilliant violet stain buffer was included
when required. Fluorescence minus one and unstained controls were used to
validate gating strategies. Just prior to analysis on the flow cytometer, DAPI
and 123count eBeads (Thermo Fisher Scientific) were added to samples.
Samples were analyzed using an LSRFortessa with FACSDiva software (BD
Biosciences) or FACSMelody with Chorus software and analyzed with FlowJo
v.9 software (FlowJo). Analysis was performed on single, live cells determined
using forward scatter height vs. area and negativity for live/dead (DAPI or
alternative viability dye). For FACS, red blood cell lysis, Fc blocking, and fluo-
rescent staining was performed as previously described and samples were
sorted into pure cell populations based on cell surface marker expression using
a FACS Fusion (BD Biosciences). For data where peritoneal populations are
expressed as cells per microliter, absolute counts were calculated using 123
eBeads and the following equation: absolute count (cells/μL) = (cell count/
eBead count) × eBead batch concentration. Final volume for cytofluorimetric
analysis was 300 μL. Thus, for example, 400 cells per microliter is equal to
1.2 ×105 cells per cavity.
Immunofluorescence. Immunofluorescence was performed as previously de-
scribed (26, 27, 44). Further details are available in SI Appendix, Materials
and Methods.
Fiji Analysis. For cell counting of F4/80, GATA6 dual immunofluorescent stains,
four random images at ×63 objective were taken from each lesion and images
quantified using Fiji plugin Cell Counter. Total nuclei were counted, as well as
cells positive for respective markers. Values were expressed as percent of total
DAPI+ cells. The area of hematoxylin/eosin-stained lesions captured using 2.5×
magnification was measured in Fiji by setting the scale to a known size (198
pixels = 500 μM) and then drawing around boundary of the lesion (excluding
peritoneal and adipose tissue) and using the measure function.
Definiens Analysis. Ly6C, F4/80 dual immunofluorescence was automatically
quantified using slide scanning and machine learning. Stained tissue sections
were imaged on a Zeiss Axioscan.Z1 (Carl Zeiss AG) at 20× using fluorescence
filters configured for DAPI, FITC, and Cy3. Whole-slide .czi files were im-
ported into TissueStudio 2.4 (Definiens AG) for automated tissue detection
followed by manual correction of regions of interest to delineate endome-
triosis lesion, peritoneum, hemorrhage, and adipose tissue. TissueStudio’s
built-in nuclear segmentation, using the DAPI channel, was applied within
these regions to identify cell objects and these objects were then classified as
positive or negative for each channel based on intensity thresholds which
were used across all samples.
Statistical Analysis. Statistical analysis was carried out in GraphPad Prism 7.02.
Data were first analyzed for normality using an Anderson Darling normality
test. If data were normally distributed, either an ANOVA with a Tukey’s post
hoc test (more than two samples) or a t test (two samples) was performed. If
data were not normally distributed, nonparametric tests were used, either
Kruskal–Wallis with a Dunn’s post hoc test (more than two samples) or a
Mann–Whitney U test (two samples). Statistical significance was reported at
P < 0.05.
Data Availability.All study data are included in the article and/or SI Appendix.
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